R B Hopkins1,2,3, N Burke4, C Von Keyserlingk4, W D Leslie5, S N Morin6, J D Adachi7, A Papaioannou8,7, L Bessette9, J P Brown9, L Pericleous10, J Tarride4,8. 1. Programs for Assessment of Technology in Health (PATH), St Joseph's Healthcare Hamilton, Hamilton, ON, Canada. hopkinr@mcmaster.ca. 2. Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada. hopkinr@mcmaster.ca. 3. PATH Research Institute, 25 Main Street West, Suite 2000, Hamilton, ON, L8P 1H1, Canada. hopkinr@mcmaster.ca. 4. Programs for Assessment of Technology in Health (PATH), St Joseph's Healthcare Hamilton, Hamilton, ON, Canada. 5. Department of Medicine, University of Manitoba, Winnipeg, MB, Canada. 6. Department of Medicine, McGill University, Montréal, QC, Canada. 7. Department of Medicine, McMaster University, Hamilton, ON, Canada. 8. Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada. 9. Department of Medicine, Laval University, Quebec City, Canada. 10. Amgen Canada Inc., Mississauga, ON, Canada.
Abstract
UNLABELLED: We estimate the current burden of illness of osteoporosis in Canada is double ($4.6 billion) our previous estimates ($2.3 billion) due to improved data capture of the multiple encounters and services that accompany a fracture: emergency room, admissions to acute and step-down non-acute institutions, rehabilitation, home-assisted or long-term residency support. INTRODUCTION: We previously estimated the economic burden of illness of osteoporosis-attributable fractures in Canada for the year 2008 to be $2.3 billion in the base case and as much as $3.9 billion. The aim of this study is to update the estimate of the economic burden of illness for osteoporosis-attributable fractures for Canada based on newly available home care and long-term care (LTC) data. METHODS: Multiple national databases were used for the fiscal-year ending March 31, 2011 (FY 2010/2011) for acute institutional care, emergency visits, day surgery, secondary admissions for rehabilitation, and complex continuing care, as well as national dispensing data for osteoporosis medications. Gaps in national data were supplemented by provincial and community survey data. Osteoporosis-attributable fractures for Canadians age 50+ were identified by ICD-10-CA codes. Costs were expressed in 2014 dollars. RESULTS: In FY 2010/2011, the number of osteoporosis-attributable fractures was 131,443 resulting in 64,884 acute care admissions and 983,074 acute hospital days. Acute care costs were $1.5 billion, an 18 % increase since 2008. The cost of LTC was 33.4 times the previous estimate ($31 million versus $1.03 billion) because of improved data capture. The cost for rehabilitation and secondary admissions increased 3.4 fold, while drug costs decreased 19 %. The overall cost of osteoporosis was over $4.6 billion, an increase of 83 % from the 2008 estimate. CONCLUSION: Since the 2008 estimate, new Canadian data on home care and LTC are available which provided a better estimate of the burden of osteoporosis in Canada. This suggests that our previous estimates were seriously underestimated.
UNLABELLED: We estimate the current burden of illness of osteoporosis in Canada is double ($4.6 billion) our previous estimates ($2.3 billion) due to improved data capture of the multiple encounters and services that accompany a fracture: emergency room, admissions to acute and step-down non-acute institutions, rehabilitation, home-assisted or long-term residency support. INTRODUCTION: We previously estimated the economic burden of illness of osteoporosis-attributable fractures in Canada for the year 2008 to be $2.3 billion in the base case and as much as $3.9 billion. The aim of this study is to update the estimate of the economic burden of illness for osteoporosis-attributable fractures for Canada based on newly available home care and long-term care (LTC) data. METHODS: Multiple national databases were used for the fiscal-year ending March 31, 2011 (FY 2010/2011) for acute institutional care, emergency visits, day surgery, secondary admissions for rehabilitation, and complex continuing care, as well as national dispensing data for osteoporosis medications. Gaps in national data were supplemented by provincial and community survey data. Osteoporosis-attributable fractures for Canadians age 50+ were identified by ICD-10-CA codes. Costs were expressed in 2014 dollars. RESULTS: In FY 2010/2011, the number of osteoporosis-attributable fractures was 131,443 resulting in 64,884 acute care admissions and 983,074 acute hospital days. Acute care costs were $1.5 billion, an 18 % increase since 2008. The cost of LTC was 33.4 times the previous estimate ($31 million versus $1.03 billion) because of improved data capture. The cost for rehabilitation and secondary admissions increased 3.4 fold, while drug costs decreased 19 %. The overall cost of osteoporosis was over $4.6 billion, an increase of 83 % from the 2008 estimate. CONCLUSION: Since the 2008 estimate, new Canadian data on home care and LTC are available which provided a better estimate of the burden of osteoporosis in Canada. This suggests that our previous estimates were seriously underestimated.
Entities:
Keywords:
Burden of illness; Canada; Fractures; Health economics; Osteoporosis
Authors: L Bessette; S Jean; M-P Lapointe-Garant; E L Belzile; K S Davison; L G Ste-Marie; J P Brown Journal: Osteoporos Int Date: 2011-09-17 Impact factor: 4.507
Authors: Brian C Lentle; Jacques P Brown; Aliya Khan; William D Leslie; Jacques Levesque; David J Lyons; Kerry Siminoski; Giuseppe Tarulli; Robert G Josse; Anthony Hodsman Journal: Can Assoc Radiol J Date: 2007-02 Impact factor: 2.248
Authors: Sara Kaffashian; Parminder Raina; Mark Oremus; Laura Pickard; Jonathan Adachi; Emmanuel Papadimitropoulos; Alexandra Papaioannou Journal: Age Ageing Date: 2011-07-20 Impact factor: 10.668
Authors: Dawn C Mackey; Li-Yung Lui; Peggy M Cawthon; Douglas C Bauer; Michael C Nevitt; Jane A Cauley; Teresa A Hillier; Cora E Lewis; Elizabeth Barrett-Connor; Steven R Cummings Journal: JAMA Date: 2007-11-28 Impact factor: 56.272
Authors: R B Hopkins; J E Tarride; W D Leslie; C Metge; L M Lix; S Morin; G Finlayson; M Azimaee; E Pullenayegum; R Goeree; J D Adachi; A Papaioannou; L Thabane Journal: Osteoporos Int Date: 2012-05-10 Impact factor: 4.507
Authors: A Svedbom; E Hernlund; M Ivergård; J Compston; C Cooper; J Stenmark; E V McCloskey; B Jönsson; J A Kanis Journal: Arch Osteoporos Date: 2013-10-11 Impact factor: 2.617
Authors: J-E Tarride; R B Hopkins; W D Leslie; S Morin; J D Adachi; A Papaioannou; L Bessette; J P Brown; R Goeree Journal: Osteoporos Int Date: 2012-03-08 Impact factor: 4.507
Authors: M Kastner; L Perrier; S E P Munce; C C Adhihetty; A Lau; J Hamid; V Treister; J Chan; Y Lai; S E Straus Journal: Osteoporos Int Date: 2017-10-18 Impact factor: 4.507
Authors: Danielle E Whittier; Elizabeth J Samelson; Marian T Hannan; Lauren A Burt; David A Hanley; Emmanuel Biver; Pawel Szulc; Elisabeth Sornay-Rendu; Blandine Merle; Roland Chapurlat; Eric Lespessailles; Andy Kin On Wong; David Goltzman; Sundeep Khosla; Serge Ferrari; Mary L Bouxsein; Douglas P Kiel; Steven K Boyd Journal: J Bone Miner Res Date: 2022-01-14 Impact factor: 6.390
Authors: Aníbal García-Sempere; Isabel Hurtado; José Sanfélix-Genovés; Clara L Rodríguez-Bernal; Rafael Gil Orozco; Salvador Peiró; Gabriel Sanfélix-Gimeno Journal: Sci Rep Date: 2017-09-18 Impact factor: 4.379